Article
Identifying simultaneous inhibition of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancer
2024-10-26
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) remains a formidable challenge with a survival rate of approximately 10%, largely due to the lack of diagnostic and therapeutic options. To identify novel therapeutic targets for PDAC, we previously developed a Drosophila melanogaster model, the ’ 4-hit ’ fly, which mimics the alterations in KRAS , TP53 , CDKN2A , and SMAD4 genes observed in PDAC. Through whole-body ge...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9beee056-4e37-518d-a661-1d386bd7dfc1
- DOI
- 10.1101/2024.10.23.619807
